Rincon lithium project: US$2.5bn cost, 60,000tpa capacity, DLE technology and 2028 production timeline
Read More Pharma Industry News Suven life sciences reports rapid-acting depression treatment breakthrough with ropanicant in phase-2a trial Suven Life Sciences’ Ropanicant delivers rapid antidepressant effects in Phase-2a trial for MDD. See the results, safety profile, and what’s next. byPallavi MadhirajuSeptember 19, 2024